Zepbound: Representing the next evolution in treatment, Zepbound has shown even greater promise in clinical trials, offering patients in search of Detroit weight loss a new level of efficacy
Integrating the result from the CVOTs in their meta-analysis, Sattar and colleagues found that the GLP-1 RA drug class may reduce the risk of hospital admission for HF by 11% (HR vs
Most common side effects are usually mild to moderate and tend to resolve on their own
Rare but serious risks include pancreatitis and gallbladder problems, so regular medical supervision is essential
Obes (Silver Spring) (2020) 28:52936
found that liraglutide, an GLP-1R agonists, reduces the activated microglia load in the cortex and dentate gyrus region of hippocampus, and the activated astrocyte load in the cortex